leukemia

Showing NaN - NaN of 135

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cognitive Aftereffects of Neurotoxicity in Children and Young

Not yet recruiting
  • Lymphoma
  • Leukemia
    • Los Angeles, California
    • +2 more
    Feb 2, 2023

    Leukemia, Lymphoma Trial in United States (SCRI-CAR22v2)

    Recruiting
    • Leukemia
    • Lymphoma
    • SCRI-CAR22v2
    • Los Angeles, California
    • +4 more
    Jan 18, 2023

    Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

    Suspended
    • Juvenile Myelomonocytic Leukemia
    • +27 more
    • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 11, 2023

    Leukemia Trial in United States (mercaptopurine, methotrexate, tretinoin)

    Completed
    • Leukemia
    • Scottsdale, Arizona
    • +209 more
    Dec 14, 2022

    Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)

    Completed
    • Leukemia
    • arsenic trioxide
    • +4 more
    • Roseville, California
    • +191 more
    Dec 14, 2022

    Blood Samples to Identify Biomarkers of Busulfan

    Active, not recruiting
    • Leukemia
    • +4 more
      • Seattle, Washington
        University of Washington
      Jan 4, 2023

      Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma AJCC v8, Clinical Stage IB Cutaneous Melanoma

      Recruiting
      • Clinical Stage I Cutaneous Melanoma AJCC v8
      • +33 more
      • Informational Intervention
      • +4 more
      • Los Angeles, California
      • +4 more
      Dec 14, 2022

      Leukemia Trial in Worldwide (Dasatinib)

      Active, not recruiting
      • Leukemia
      • Birmingham, Alabama
      • +173 more
      Dec 1, 2022

      Selection of Allogeneic Hematopoietic Cell Donors Based on KIR

      Active, not recruiting
      • Leukemia
      • KIR genotyping
      • HLA genotyping
      • Tampa, Florida
      • +9 more
      Nov 29, 2022

      Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in United States (CYNK-001)

      Recruiting
      • Leukemia
      • +19 more
      • CYNK-001
      • Denver, Colorado
      • +9 more
      Sep 9, 2022

      Leukemia, Lymphoma Trial in Canada, United States (Patient-derived CD19- and CD22 specific CAR)

      Recruiting
      • Leukemia
      • Lymphoma
      • Patient-derived CD19- and CD22 specific CAR
      • Los Angeles, California
      • +4 more
      Apr 2, 2022

      Leukemia, Precursor b-Cell Lymphoblastic Leukemia-Lymphoma, ACUTE LYMPHOBLASTIC LEUKEMIA Trial in Worldwide (inotuzumab

      Active, not recruiting
      • Leukemia
      • +2 more
      • inotuzumab ozogamicin-dose level 2
      • Inotuzumab ozogamicin-dose level 1
      • Los Angeles, California
      • +45 more
      Mar 9, 2022

      Leukemia Trial in Seattle (Patient-derived CD22-specific CAR T-cells also expressing an EGFRt)

      Active, not recruiting
      • Leukemia
      • Patient-derived CD22-specific CAR T-cells also expressing an EGFRt
      • Seattle, Washington
        Seattle Children's Hospital
      Feb 15, 2022

      Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

      Active, not recruiting
      • Leukemia
      • Birmingham, Alabama
      • +184 more
      Feb 4, 2022

      Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

      Completed
      • Leukemia
      • Birmingham, Alabama
      • +197 more
      Mar 22, 2021

      Leukemia, Lymphoma Trial in Seattle (rituximab, fludarabine phosphate, pixantrone dimaleate)

      Withdrawn
      • Leukemia
      • Lymphoma
      • rituximab
      • +2 more
      • Seattle, Washington
        Cell Therapeutics, Incorporated
      Oct 14, 2020

      Breast Carcinoma, Cancer Survivor, Depression Trial in United States (procedure, other, behavioral)

      Completed
      • Breast Carcinoma
      • +12 more
      • Management of Therapy Complications
      • +3 more
      • Los Angeles, California
      • +5 more
      Oct 8, 2020

      Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis, Seattle (biological,

      Completed
      • Acute Myeloid Leukemia
      • +12 more
      • filgrastim
      • +6 more
      • Minneapolis, Minnesota
      • +1 more
      Sep 9, 2020

      GVHD, Leukemia, MDS Trial in New Haven, Seattle (drug, radiation, other, procedure, biological)

      Terminated
      • Graft Versus Host Disease
      • +2 more
      • Fludarabine Phosphate
      • +7 more
      • New Haven, Connecticut
      • +1 more
      Aug 10, 2020

      Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)

      Terminated
      • Leukemia
      • rituximab
      • fludarabine phosphate
      • Anniston, Alabama
      • +386 more
      Apr 9, 2020

      Leukemia Trial in Worldwide (biological, drug, procedure)

      Unknown status
      • Leukemia
      • anti-thymocyte globulin
      • +21 more
      • Boston, Massachusetts
      • +12 more
      Jul 29, 2019

      Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Seattle (aldesleukin)

      Completed
      • Leukemia
      • +2 more
      • aldesleukin
      • Seattle, Washington
        University of Washington Medical Center
      Feb 25, 2019

      Aplastic Anemia, Leukemia, Myelodysplastic Syndrome Trial in United States (Busulfan, fludarabine, & cyclophosphamide with

      Completed
      • Aplastic Anemia
      • +2 more
      • Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
      • CliniMACS device
      • Boston, Massachusetts
      • +5 more
      Jun 14, 2018